4.0 Article

Metacognition in functional cognitive disorder- a potential mechanism and treatment target

Journal

COGNITIVE NEUROPSYCHIATRY
Volume 24, Issue 5, Pages 311-321

Publisher

ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
DOI: 10.1080/13546805.2019.1651708

Keywords

Functional cognitive disorder; metacognition; treatment; mechanism

Categories

Funding

  1. NIHR Academic Clinical Fellowship
  2. NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust
  3. University College London
  4. Mental Health and Justice Project - Wellcome Trust [203376/2/16/Z]
  5. Wellcome Trust [203147/Z/16/Z]
  6. Sir Henry Dale Fellowship - Wellcome Trust
  7. Sir Henry Dale Fellowship - Royal Society [206648/Z/17/Z]

Ask authors/readers for more resources

Introduction: Functional Cognitive Disorder (FCD) is common. Despite this, there is no evidence-based consensus on how to treat FCD. Poor metacognitive ability has been suggested as a key mechanism underlying the disorder. This paper evaluates the proposal that strategies which improve metacognition could provide a mechanistically plausible translational therapy. Methods: We reviewed the existing literature relating to metacognition in FCD, previous strategies to improve metacognitive ability in FCD and whether metacognitive performance can be modulated. Results: Though limited, there is evidence to suggest that metacognition is impaired in FCD. Converging evidence from neuroimaging studies suggests that metacognitive performance can be modulated. The effectiveness of existing strategies to improve metacognition including cognitive training, psychoeducation and lifestyle interventions have been equivocal. Recently, a potential treatment option has emerged in the form of a computer-based metacognitive training paradigm. Conclusions: There is an urgent need for effective treatments in FCD. Impaired metacognition may be a plausible therapeutic target but, in the first instance, further research is required to demonstrate deficits in local metacognitive ability in FCD patients when measured objectively. If so, clinical trials of interventions, such as computerised metacognitive training, are required to evaluate their effectiveness in improving FCD symptoms.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available